摘要 |
<p>NEW MATERIAL:A 4,5-dehydro-6-oxoprostaglandin E1 shown by the formulaI (R<1> and R<2> are H or OH-protecting group; R3 is H or 1-10C lower alkyl) and its acid addition salt when R<3> is H. EXAMPLE:(E)-DELTA<4>-6-Oxoprostaglandin F1alpha methylester 11, 15-bis t-butylsilyl ether. USE:A remedy or preventive for diseases caused by thrombotic diseases, antiasthmatic antiulcer, and hypotensor. Having inhibiting action on blood platelet aggregation, hypotensive action, and relaxing action on smooth muscle. PROCESS:A 4,5-dehydro-6-oxoprostaglanidin F1alpha shown by the formula II (R<11> and R<21> are OH-protecting group; R<31> is H or 1-10C lower alkyl) is oxidized, and if necessary, the protecting group is removed, the oxidized compound is hydrolyzed and esterified, to give a compound shown by the formulaI.</p> |